Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis.

BACKGROUND Autoimmune thyroid disease (AITD) includes Graves disease (GD) and Hashimoto thyroiditis (HT), which partially share immunological features. Determining the genetic basis that distinguishes GD and HT is a key to understanding the differences between these 2 related diseases. AIM The aims of this study were to identify HLA antigens that can explain the immunopathological difference between GD and HT and to elucidate epistatic interactions between protective and susceptible HLA alleles, which can delineate the distinct function of HLA in AITD etiology. DESIGN We genotyped 991 patients with AITD (547 patients with GD and 444 patients with HT) and 481 control subjects at the HLA-A, HLA-C, HLA-B, DRB1, DQB1, and DPB1 loci. A direct comparison of HLA antigen frequencies between GD and HT was performed. We further analyzed an epistatic interaction between the susceptible and protective HLA alleles in the development of GD and HT. RESULTS We identified 4 and 2 susceptible HLA molecules primarily associated with GD and HT, respectively, HLA-B*35:01, HLA-B*46:01, HLA-DRB1*14:03, and HLA-DPB1*05:01 for GD and HLA-A*02:07 and HLA-DRB4 for HT. In a direct comparison between GD and HT, we identified GD-specific susceptible class II molecules, HLA-DP5 (HLA-DPB1*05:01; Pc = 1.0 × 10(-9)) and HLA-DR14 (HLA-DRB*14:03; Pc = .0018). In contrast, HLA components on 3 common haplotypes in Japanese showed significant protective effects against the development of GD and HT (HLA-A*24:02-C*12:02-B*52:01-DRB1*15:02-DQB1*06:01-DPB1*09:01 and HLA-A*24:02-C*07:02-B*07:02-DRB1*01:01-DQB1*05:01-DPB1*04:02 haplotypes for GD and HLA-A*33:03-C*14:03-B*44:03-DRB1*13:02-DQB1*06:04-DPB1*04:01 haplotype for GD and HT). Interestingly, the representative protective HLA, HLA-DR13 (HLA-DRB1*13:02), was epistatic to susceptible HLA-DP5 in controlling the development of GD. CONCLUSION We show that HLA exerts a dual function, susceptibility and resistance, in controlling the development of GD and HT. We also show that the protective HLA allele is partially epistatic to the susceptible HLA allele in GD.

[1]  Tatsuo Ito,et al.  Effect of human leukocyte antigen class II genes on Hashimoto's thyroiditis requiring replacement therapy with levothyroxine in the Japanese population. , 2013, Human immunology.

[2]  Yusuke Nakamura,et al.  Identification of independent risk loci for Graves’ disease within the MHC in the Japanese population , 2011, Journal of Human Genetics.

[3]  Y. Tomer,et al.  Cutting Edge: The Etiology of Autoimmune Thyroid Diseases , 2011, Clinical reviews in allergy & immunology.

[4]  J. Franklyn,et al.  Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease , 2008, Genes and Immunity.

[5]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[6]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[7]  K. Park,et al.  Association of HLA-DR and -DQ genes with Graves disease in Koreans. , 2005, Human immunology.

[8]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[9]  L. Hegedüs,et al.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. , 2001, The Journal of clinical endocrinology and metabolism.

[10]  R. Volpe,et al.  HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. , 1999, The Journal of clinical endocrinology and metabolism.

[11]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[12]  T. Sasazuki,et al.  HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. , 1995, Human immunology.

[13]  T. Awata,et al.  HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. , 1994, Endocrine journal.

[14]  T. Sasazuki,et al.  HLA-A and DPB1 loci confer susceptibility to Graves' disease. , 1992, Human immunology.

[15]  S. Sakaguchi,et al.  HLA-BW35 and B5 in Japanese patients with Graves' disease. , 1977, Acta endocrinologica.

[16]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.

[17]  C. Lindgren,et al.  •Australo-Anglo-American Spondylitis Consortium (TASC), et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007 Nov; 39(11):1329-37. * Member of the consortium and T2D analysis subgroup. PMID: 17952073. , 2007 .

[18]  A. Kimura,et al.  HLA-DPB1*0202 is associated with a predictor of good prognosis of Graves' disease in the Japanese. , 2006, Human immunology.

[19]  J. Todd,et al.  Regression mapping of association between the human leukocyte antigen region and Graves disease. , 2005, American journal of human genetics.

[20]  R Volpé,et al.  Autoimmune thyroid disease. , 1984, Hospital practice.